Epigallocatechin Gallate (EGCG) Improves Anti-Angiogenic State, Cell Viability, and Hypoxia-Induced Endothelial Dysfunction by Downregulating High Mobility Group Box 1 (HMGB1) in Preeclampsia

BACKGROUND: Preeclampsia (PE) is a serious complication of pregnancy with no effective therapy. This study assessed whether epigallocatechin gallate (EGCG) could reduce the production of anti-angiogenic factors, improve cell viability, and suppress endothelial dysfunction in vitro via regulating hig...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Min, Peng, Julan, Xiang, Lanhua, Yang, Xinhuang, Wang, Xianghua, Zhu, Yanbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2020
Materias:
Lab/In Vitro Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574359/
https://www.ncbi.nlm.nih.gov/pubmed/33056943
http://dx.doi.org/10.12659/MSM.926924

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574359/
https://www.ncbi.nlm.nih.gov/pubmed/33056943
http://dx.doi.org/10.12659/MSM.926924

Ejemplares similares